In this study, our hypothesis was that miR-181 family members regulate OPN expression in both the context of direct glioma cells effects and the immune system and that the upregulation of miR-181 in tumor cells or the systemic delivery of the microRNAs will have anti-tumor effects. Here, SPP1 is linked to glioma.